Health
AstraZeneca U.S. COVID-19 vaccine trial results likely in late-January, says health official – Reuters
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief…
By Reuters Staff
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. governments Operation Warp Speed program said on Wednesday.
The British drugmaker…
-
Business17 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business16 hours agoHere’s what analysts expect for the BHP share price in the coming year